Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events
We present a personal critical review of the long-term mortality and kidney failure outcomes of participants in the Systolic Blood Pressure Intervention Trial (SPRINT) trial and their implication for the treatment of hypertension, the management of chronic kidney disease (CKD) and the research agenda.
Authors
- José Manuel Valdivielso (ORCID: https://orcid.org/0000-0003-1343-0184)
- Pantelis Sarafidis (ORCID: https://orcid.org/0000-0002-9174-4018)
- Shanmugakumar Chinnappa (ORCID: https://orcid.org/0000-0002-9929-0567)
- Beatriz Fernández‐Fernández (ORCID: https://orcid.org/0000-0002-6727-1943)
- Alberto Ortíz (ORCID: https://orcid.org/0000-0002-9805-9523)
Institutions
- University of Leeds (GB)
- Universitat de Lleida (ES)
- Aristotle University of Thessaloniki (GR)
- Instituto de Salud Carlos III (ES)
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust (GB)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Instituto de Investigación Biomédica de Lleida (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1093/ndt/gfaf053
- Citations
- 2
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 2.86